Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens
- DOI
- 10.1016/j.ctrv.2016.09.001
- Published
- 2016-11
- Container
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ctrv.2016.09.001,
title = {Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens},
author = {Arndt Vogel and Fortunato Ciardiello and Richard A. Hubner and Jean-Frédéric Blanc and Alfredo Carrato and Yoojung Yang and Dipen A. Patel and Varun Ektare and Floris A. de Jong and Sharlene Gill},
year = {2016},
journal = {Cancer Treatment Reviews},
doi = {10.1016/j.ctrv.2016.09.001},
url = {https://doi.org/10.1016/j.ctrv.2016.09.001}
}RIS
TY - JOUR TI - Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens AU - Arndt Vogel AU - Fortunato Ciardiello AU - Richard A. Hubner AU - Jean-Frédéric Blanc AU - Alfredo Carrato AU - Yoojung Yang AU - Dipen A. Patel AU - Varun Ektare AU - Floris A. de Jong AU - Sharlene Gill PY - 2016 JO - Cancer Treatment Reviews DO - 10.1016/j.ctrv.2016.09.001 UR - https://doi.org/10.1016/j.ctrv.2016.09.001 ER -
APA
Vogel, A., Ciardiello, F., Hubner, R. A., Blanc, J., Carrato, A., Yang, Y., Patel, D. A., Ektare, V., Jong, F. A. D., & Gill, S. (2016). Post-gemcitabine therapy for patients with advanced pancreatic cancer – A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2016.09.001
Source records
- crossref · retrieved 2026-09-25T18:00:54.176Z